190 related articles for article (PubMed ID: 27440271)
41. Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model.
Wang Y; Zheng C; Liang B; Zhao H; Qian J; Liang H; Feng G
J Vasc Interv Radiol; 2011 Nov; 22(11):1606-12. PubMed ID: 21959058
[TBL] [Abstract][Full Text] [Related]
42. Comparing HCC arterial tumour vascularisation on baseline imaging and after lipiodol cTACE: how do estimations of enhancing tumour volumes differ on contrast-enhanced MR and CT?
Luedemann WM; Geisel D; Gebauer B; Schnapauff D; Chapiro J; Wieners G; Steffen I; Kahn J
Eur Radiol; 2020 Mar; 30(3):1601-1608. PubMed ID: 31811428
[TBL] [Abstract][Full Text] [Related]
43. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.
Hyder O; Marsh JW; Salem R; Petre EN; Kalva S; Liapi E; Cosgrove D; Neal D; Kamel I; Zhu AX; Sofocleous CT; Geschwind JF; Pawlik TM
Ann Surg Oncol; 2013 Nov; 20(12):3779-86. PubMed ID: 23846786
[TBL] [Abstract][Full Text] [Related]
44. Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma.
Cucchetti A; Trevisani F; Cappelli A; Mosconi C; Renzulli M; Pinna AD; Golfieri R
Dig Liver Dis; 2016 Jul; 48(7):798-805. PubMed ID: 27263056
[TBL] [Abstract][Full Text] [Related]
45. Antitumoural hydroxyapatite nanoparticles-mediated hepatoma-targeted trans-arterial embolization gene therapy: in vitro and in vivo studies.
Li G; Ye L; Pan J; Long M; Zhao Z; Yang H; Tian J; Wen Y; Dong S; Guan J; Luo B
Liver Int; 2012 Jul; 32(6):998-1007. PubMed ID: 22340582
[TBL] [Abstract][Full Text] [Related]
46. Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.
Li J; Zhou M; Liu F; Xiong C; Wang W; Cao Q; Wen X; Robertson JD; Ji X; Wang YA; Gupta S; Li C
Radiology; 2016 Nov; 281(2):427-435. PubMed ID: 27347765
[TBL] [Abstract][Full Text] [Related]
47. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
[TBL] [Abstract][Full Text] [Related]
48. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
Song MJ; Chun HJ; Song DS; Kim HY; Yoo SH; Park CH; Bae SH; Choi JY; Chang UI; Yang JM; Lee HG; Yoon SK
J Hepatol; 2012 Dec; 57(6):1244-50. PubMed ID: 22824821
[TBL] [Abstract][Full Text] [Related]
49. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.
Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H
J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344
[TBL] [Abstract][Full Text] [Related]
50. Radiotherapy Synergizes with the Hypoxia-Activated Prodrug Evofosfamide: In Vitro and In Vivo Studies.
Takakusagi Y; Kishimoto S; Naz S; Matsumoto S; Saito K; Hart CP; Mitchell JB; Krishna MC
Antioxid Redox Signal; 2018 Jan; 28(2):131-140. PubMed ID: 28741367
[TBL] [Abstract][Full Text] [Related]
51. Antagonism in effectiveness of evofosfamide and doxorubicin through intermolecular electron transfer.
Anderson RF; Li D; Hunter FW
Free Radic Biol Med; 2017 Dec; 113():564-570. PubMed ID: 29111232
[TBL] [Abstract][Full Text] [Related]
52. Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion.
Duan F; Wang EQ; Lam MG; Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Kuo WT; Hofmann LV; Sze DY
Radiology; 2016 Feb; 278(2):612-21. PubMed ID: 26334787
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of transarterial embolization with arsenic trioxide oil emulsion in a rabbit VX2 liver tumor model.
Kim HJ; Shin JH; Kim TH; Kim EY; Park YS; Park CS; Song HY
J Vasc Interv Radiol; 2009 Oct; 20(10):1365-70. PubMed ID: 19713126
[TBL] [Abstract][Full Text] [Related]
54. TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging.
Peeters SG; Zegers CM; Biemans R; Lieuwes NG; van Stiphout RG; Yaromina A; Sun JD; Hart CP; Windhorst AD; van Elmpt W; Dubois LJ; Lambin P
Clin Cancer Res; 2015 Jul; 21(13):2984-92. PubMed ID: 25805800
[TBL] [Abstract][Full Text] [Related]
55. [The effects of lipiodol-hydroxyapatite nanoparticle on apoptosis, proliferation, and angiogenesis in hepatic tumor: experiment with rabbits].
Sun ZG; Chen XP; Huang ZY; Yang GH; Guan J; Hu DY; Mu LD; Xia XG; Li GP; Zhang WG; Li Z
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):409-13. PubMed ID: 17456384
[TBL] [Abstract][Full Text] [Related]
56. Radiofrequency ablation combined with transcatheter therapy in rabbit VX2 liver tumors: effects and histopathological characteristics.
Duan X; Zhou G; Han X; Ren J; Zheng C; Liang H; Feng G
Acta Radiol; 2015 Jan; 56(1):87-96. PubMed ID: 24425792
[TBL] [Abstract][Full Text] [Related]
57. Combination treatment with hypoxia-activated prodrug evofosfamide (TH-302) and mTOR inhibitors results in enhanced antitumor efficacy in preclinical renal cell carcinoma models.
Sun JD; Ahluwalia D; Liu Q; Li W; Wang Y; Meng F; Bhupathi D; Matteucci MD; Hart CP
Am J Cancer Res; 2015; 5(7):2139-55. PubMed ID: 26328245
[TBL] [Abstract][Full Text] [Related]
58. Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review.
Nishikawa H; Kita R; Kimura T; Osaki Y
Anticancer Res; 2014 Dec; 34(12):6877-86. PubMed ID: 25503113
[TBL] [Abstract][Full Text] [Related]
59. Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads.
Choi JW; Cho HJ; Park JH; Baek SY; Chung JW; Kim DD; Kim HC
PLoS One; 2014; 9(12):e115898. PubMed ID: 25551760
[TBL] [Abstract][Full Text] [Related]
60. Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a Placebo.
Pinter M; Ulbrich G; Sieghart W; Kölblinger C; Reiberger T; Li S; Ferlitsch A; Müller C; Lammer J; Peck-Radosavljevic M
Radiology; 2015 Dec; 277(3):903-12. PubMed ID: 26131911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]